Vaccines

US outlines sweeping plan to provide free COVID-19 vaccines WASHINGTON (AP) — The federal government outlined a sweeping plan Wednesday to make vaccines for COVID-19 available for free to all Americans, even as polls show a strong undercurrent of... AP NEWS

WASHINGTON (AP) — The federal government outlined a sweeping plan Wednesday to make vaccines for COVID-19 available for free to all Americans, even as polls show a strong undercurrent of skepticism rippling across the land.

Here's why a vaccine will not stop the Covid-19 pandemic right away Experts say even if a coronavirus vaccine was approved in January or even earlier, it will be many months before it has an effect on the pandemic. Maggie Fox, CNN CNN

...   while vaccine manufacturers, public health experts and the federal government are all confident one or more of the coronavirus vaccines being tested now will be shown to work safely by the end of the year, the US and the world will still be a long way from ending the pandemic. 

https://news.yahoo.com/poll-number-of-americans-willing-to-get-a-vaccination-falls-as-fears-mount-that-trump-is-putting-politics-before-safety-203727770.html

In early May, most Americans (55 percent) said they would get vaccinated for COVID-19 if and when a vaccine becomes available. 

Now, four months later, less than a third of Americans (32 percent) say they plan to get vaccinated, according to the latest Yahoo News/YouGov poll — a stunning 23-point decline that reflects rising concern about the politicization of the vaccine process and underscores how challenging it will be to stop the pandemic through vaccination alone.

Vaccine by Nov. 3? Halted study explains just how unlikely WASHINGTON (AP) — The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be “no compromises” on safety in the race to develop the shot, the chief... AP NEWS

WASHINGTON (AP) — The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be “no compromises” on safety in the race to develop the shot, the chief of the National Institutes of Health told Congress on Wednesday.